Panakes Partners logo

Panakes Partners

Europe, Lombardia, Italy, Milano

Description

Panakes Partners is a Venture Capital investor that finances Life Sciences companies.

Investor Profile

Panakes Partners has made 36 investments, with 9 in the past 12 months and 53% as lead.

Stage Focus

  • Series B (36%)
  • Series A (25%)
  • Series Unknown (14%)
  • Seed (11%)
  • Series C (11%)
  • Series D (3%)

Country Focus

  • Italy (42%)
  • Switzerland (17%)
  • United Kingdom (14%)
  • Ireland (11%)
  • United States (6%)
  • France (6%)
  • Germany (3%)
  • The Netherlands (3%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Therapeutics
  • Manufacturing
  • Robotics
  • Health Diagnostics
  • Clinical Trials
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Panakes Partners frequently co-invest with?

Supernova Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 3
415 Capital
Europe, Bayern, Germany, Munich
Co-Investments: 2
LIFTT
Europe, Piemonte, Italy, Turin
Co-Investments: 3
Fountain Healthcare Partners
North America, New York, United States, New York
Co-Investments: 7
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Indaco Venture Partners
Europe, Lombardia, Italy, Milan
Co-Investments: 3
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
IP Group
Europe, England, United Kingdom, London
Co-Investments: 4
Club degli Investitori
Europe, Piemonte, Italy, Torino
Co-Investments: 3
CDP Venture Capital
Europe, Lazio, Italy, Rome
Co-Investments: 3

What are some of recent deals done by Panakes Partners?

Salvia BioElectronics

Eindhoven, Noord-Brabant, The Netherlands

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

BiotechnologyMedical DeviceTherapeutics
Series BMay 27, 2025
Amount Raised: $60,425,647
DeepUll

Barcelona, Catalonia, Spain

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

BiotechnologyLife Science
Series CApr 29, 2025
Amount Raised: $57,074,303
Neuromod Devices

Dublin, Dublin, Ireland

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

BiotechnologyClinical TrialsHealth CareMedicalMedical Device
Series BMar 11, 2025
Amount Raised: $10,853,438
Relief

Pontedera, Toscana, Italy

Relief provides treatments for urinary incontinence.

Health CareMedicalMedical Device
Series UnknownMar 5, 2025
Amount Raised: $1,080,000
Approxima

Milan, Lombardia, Italy

Approxima is an early-stage MedTech startup that is creating a percutaneous tricuspid valve replacement method.

Medical Device
Series AFeb 20, 2025
Amount Raised: $7,615,264
Endovascular Engineering

Menlo Park, California, United States

Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions.

Clinical TrialsMedicalMedical Device
Series BFeb 18, 2025
Amount Raised: $42,000,000
TENSIVE

Milano, Lombardia, Italy

Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to substitute silicone implants.

BiotechnologyHealth CareMedicalMedical Device
Series AJan 29, 2025
Amount Raised: $14,615,808
Lymphatica Medtech

Ecublens, Vaud, Switzerland

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

BiotechnologyHealth CareMedicalMedical Device
Series BOct 8, 2024
Amount Raised: $19,646,128
Alesi Surgical

Cardiff, Cardiff, United Kingdom

Alesi Surgical develops and commercialises products that improve the safety

BiotechnologyHealth CareTherapeutics
Series UnknownSep 19, 2024
Amount Raised: $6,640,653
CorFlow Therapeutics

Baar, Zug, Switzerland

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

BiotechnologyManufacturingMedicalMedical Device
Series BSep 10, 2024
Amount Raised: $48,489,444